The application relates to pharmaceutical formulation and a process for its preparation. The pharmaceutical formulation comprises cinnamic acid and at least one excipient. The pharmaceutical formulation of the present disclosure has improved patient compliance, and reduced adverse effects. The pharmaceutical formulation of the present disclosure can be used in the treatment of cyclophosphamide induced neutropenia. …
Pharmaceutical Compositions Comprising Picroside
The patent discloses a pharmaceutical composition comprising picroside isolated from Picrorrhize kurroa. The composition contains Picroside I as an active ingredient for treating drug-induced immunopathy such as neutropenia. Methods of isolating Picroside I and Picroside II, and preparing the compositions have also been disclosed herein. The said composition of Picroside I can be a solid oral …
Tracheostomy Tube
Origiin ID: VR-02 A double cannula tracheostomy tube: A tracheostomy tube for insertion through an incision on the anterior portion of the neck to assist in patient breathing. The tracheostomy tube comprises an inner cannula, an outer cannula, a plurality of hinges, a circular ring, a knob and a cuff. The outer cannula is inserted …
An aqueous corticosteroid nasal spray solution and method thereof
The invention relates to a pharmaceutical composition of corticosteroid aqueous nasal spray solution and a method of preparation thereof that is safe and cost effective. The method of this patent involves relatively lesser number of steps and does not require MDRS studies, thus saving expenses on analysis and batch release tests. This patent provides an …
Dry powder inhalation (DPI) formulation
The invention relates to a dry powder inhalation (DPI) formulation and a process for its preparation. The dry powder inhalation formulation comprises micronized favipiravir/Ivermectin, first lactose, second lactose, and optionally at least one excipient. The dry powder formulation of this patent increases the bioavailability of the Favipiravir/Ivermectin, patient compliance, and reduced adverse effects. Patent Status: …
Pharmaceutical company for sale: Navi Mumbai
Project ID: ORSP-01, Asking Price: 45 cr The facility spans 5,020 sq. meters of land installed, operational and well-maintained machineries. The facility is equipped to manufacture numerous popular medicines, healthcare, and personal care goods in the form of Tablets, Capsules, Liquid Orals, Creams, Ointments and External Preparations etc. WhatsApp at +91 7483 806 607 to …
Cisplatin Nanoparticle Composition (Oral Administration)
ID: VR-01 Cisplatin is a chemotherapy drug used to treat a variety of cancers, including testicular, lung, bladder, cervical, and ovarian cancers. It’s an alkylating agent that contains platinum, which damages DNA and stops cells from dividing. Cisplatin Market size was valued at USD 14.2 Billion in 2023 and is projected to reach USD 25.6 Billion by 2031, …
Solar Tracking System
ID: SP-01 It is a disruptive solar tracking technology that overcomes the shortcomings of a Single-axis tracker. Asun 2 Axis Tracker guarantees a consistently higher yield across seasons and geographies by tracking along the seasonal shift (N/S) in the Sun’s path and daily East-West tracking without any significant increase in capital cost. This innovative solar …
Voice Prosthesis device
ID: VR-03 This medical device is designed to help individuals who have undergone a laryngectomy (removal of the voice box) regain their ability to speak. The prosthesis features a cylindrical structure with washers at both ends—an inner washer at one end and an outer washer at the other. A partial shutter, made of biocompatible platinum-cured …
Telepresence robot with full body control
ID: VJ-01 The invention provides a humanoid telepresence robot to make human interaction more impactful. This robot and all its movements can be controlled from remote location over internet. The robot makes human hand gestures and operates like a human. This robot does not need another human on-site assistance to operate or manoeuvre. Entire system …